MARKET

DTCFF

DTCFF

Defence Therapeu
OTCMQB
0.410
-0.014
-3.28%
Closed 14:50 06/03 EDT
OPEN
0.434
PREV CLOSE
0.424
HIGH
0.449
LOW
0.393
VOLUME
14.59K
TURNOVER
6.21K
52 WEEK HIGH
0.779
52 WEEK LOW
0.317
MARKET CAP
23.51M
P/E (TTM)
-5.1186
1D
5D
1M
3M
1Y
5Y
1D
Defence Therapeutics appoints biopharma executive John Beaver to board
PUBT · 1d ago
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors
Newsfile · 1d ago
Weekly Report: what happened at DTCFF last week (0525-0529)?
Weekly Report · 3d ago
Defence Therapeutics appoints ADC veteran John Lambert to board
PUBT · 3d ago
Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors
Newsfile · 3d ago
Defence Therapeutics director Meterissian resigns to join scientific advisory board
PUBT · 5d ago
Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian
Newsfile · 5d ago
Weekly Report: what happened at DTCFF last week (0518-0522)?
Weekly Report · 05/25 10:49
More
About DTCFF
Defence Therapeutics Inc. is a Canada-based clinical-stage biotechnology company. The Company is engaged in developing and engineering the antibody drug conjugates (ADC) products using its proprietary platform. Its principal business activity is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological-/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The core of its therapeutics platform is the ACCUM technology, which enables precision delivery ADCs in their intact form to target cells. The Company is focused on research, development and advancement of the main products using its Accum technology, which include ADC targeting various cancers, Anti-cancer AccuTOX program, Mesenchymal stromal cell-based vaccine (ARM-X) targeting cancer, mRNA vaccination, Cervical cancer vaccine, and Radio-immunoconjugates (RIC) targeting various cancers.

Webull offers Defence Therapeutics Inc stock information, including OTCMQB: DTCFF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DTCFF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DTCFF stock methods without spending real money on the virtual paper trading platform.